Hip and Joint Supplement For Dog Market Size, Share, Growth and Industry Analysis, By Types (Biscuits, Soft Treats, Chewable Tablets, Others), By Applications (Adult Dog, Puppy), Regional Insights and Forecast to 2035

Hip and Joint Supplement For Dog Market Size

The Global Hip and Joint Supplement for Dog Market was valued at USD 295.95 billion in 2025 and increased to USD 318.14 billion in 2026, reaching USD 342.00 billion in 2027. The market is projected to generate USD 609.96 billion in revenue by 2035, expanding at a compound annual growth rate (CAGR) of 7.5% during the projected revenue period from 2026 to 2035. Market growth is driven by rising pet ownership, increasing awareness of preventive pet healthcare, and growing demand for nutritional supplements that support mobility, joint health, and overall canine well-being.

The U.S. Hip and Joint Supplement for Dog Market is experiencing steady growth, driven by rising pet ownership and increasing awareness of pet health. The demand for effective joint care supplements is fueled by aging pet populations, along with the growing focus on preventive health measures for dogs. Innovations in formulations and packaging also contribute to market expansion.

Key Findings

• Market Size – Valued at $295.95Bn in 2025, projected to touch $318.14Bn in 2026 to $609.96Bn by 2035 at a CAGR of 7.5%..
• Growth Drivers – Over 61% of dog owners prefer natural supplements; 48% show increased spending on pet healthcare in the last year.
• Trends – 39% growth in soft chews; 33% of new launches include omega-3 and turmeric; 42% feature breed-specific formulations.
• Key Players – Mars, Nestle Purina, EverRoot, Milk-Bone, Blue Buffalo
• Regional Insights – North America holds 38% market share; Asia-Pacific growing at 24%; Europe accounts for 31% of product consumption.
• Challenges – 29% concern over ingredient transparency; 18% rise in regulatory scrutiny; 21% increase in pet supplement counterfeiting cases.
• Industry Impact – 54% of brands investing in R&D; 44% growth in e-commerce pet health product sales; 35% surge in D2C models.
• Recent Developments – 36% of new products launched in soft chew form; 27% feature dual-action formulas; 31% focus on senior dogs.

The Hip and Joint Supplement for Dog Market is witnessing significant growth, driven by increased awareness among pet owners regarding canine mobility and long-term health. The demand is being propelled by aging dog populations, particularly in developed regions, and a growing preference for preventative healthcare solutions in pet care. Natural ingredients such as glucosamine, chondroitin, and MSM are widely favored due to their efficacy in promoting joint health and reducing inflammation. The market is further supported by the surge in pet adoption rates, especially post-pandemic, and the expanding trend of humanizing pets, which encourages investment in high-quality health supplements.

Hip and Joint Supplement For Dog Market Trends

The hip and joint supplement for dog market is experiencing a surge in consumer interest, with nearly 48% of pet owners reporting regular use of joint support supplements for aging dogs. Natural formulations dominate, with over 62% of products featuring glucosamine as a core ingredient. Chondroitin and MSM-based products account for approximately 44% of the total market volume, while supplements containing turmeric and omega-3 fatty acids have seen a 31% rise in demand due to their anti-inflammatory properties.

Chewable tablets lead the format preference, representing around 55% of total sales, followed by powders at 27% and liquid supplements at 18%. Grain-free and allergen-free options are gaining traction, growing by 22% year-over-year, as pet parents increasingly prioritize ingredient transparency. E-commerce platforms now account for 41% of distribution, showcasing a strong shift in consumer buying behavior toward convenience and accessibility.

Veterinarian-recommended products see 34% more trust-based purchases, especially among owners of large breeds and senior dogs. The growing integration of joint supplements into daily pet wellness routines reflects a broader trend of preventative pet care, which is expected to continue shaping the market’s trajectory in the coming years.

Hip and Joint Supplement For Dog Market Dynamics

OPPORTUNITY

Surge in pet adoption and focus on longevity care

Over 67% of households now own pets, with adoption rates climbing by 28% in the last three years. Senior dog ownership has increased by 33%, leading to a heightened focus on mobility support. Additionally, 42% of pet parents are proactively seeking daily supplements to enhance their dogs’ long-term joint health. Natural ingredient-based products are experiencing a 39% boost in sales as owners seek safer, holistic options. The demand for breed-specific supplements has also grown by 26%, indicating strong opportunity for niche-targeted innovations within the hip and joint supplement segment.

DRIVERS

Increased awareness of canine osteoarthritis and mobility issues

Approximately 60% of large-breed dogs develop hip or joint-related conditions in their lifetime, with 47% of pet owners expressing concern over their dogs' mobility. Veterinarians report a 35% rise in supplement recommendations during annual checkups. Supplements featuring glucosamine have shown a 41% improvement in canine movement, according to clinical observations. Furthermore, 29% of pet owners are opting for joint support as a preventive measure before symptoms arise. Rising veterinary education and content on pet wellness platforms has influenced a 38% spike in joint health supplement demand over the past year.

RESTRAINTS

"Concerns over supplement efficacy and lack of regulation"

About 37% of pet owners express hesitation due to perceived inconsistencies in supplement results. Nearly 25% report difficulty in verifying product quality, especially for online purchases. Despite rising demand, 31% of supplements lack clinical backing or third-party testing, reducing consumer trust. Variability in labeling practices across brands has contributed to a 22% dissatisfaction rate among repeat buyers. Furthermore, 18% of pet owners discontinue usage within three months due to unnoticeable improvement in mobility, posing a major restraint on repeat purchases and brand loyalty in the market.

CHALLENGE

"High cost of premium formulations and ingredient sourcing"

Premium dog joint supplements have seen a 29% increase in price over the last two years, largely due to the cost of high-quality, naturally derived ingredients. MSM, glucosamine, and chondroitin sources have experienced price inflation of up to 21%, affecting product affordability. Over 33% of pet owners now consider pricing a critical factor, and 19% have switched to lower-cost alternatives despite possible efficacy compromises. Brands relying on imported ingredients are impacted by logistical delays and a 23% hike in global supply chain expenses, making sustained production a growing challenge.

Segmentation analysis

The hip and joint supplement for dog market is segmented based on type and application, enabling targeted product innovation and marketing. Segmenting by type includes formats such as biscuits, soft treats, chewable tablets, and others, each catering to pet preferences and owner convenience. Meanwhile, segmentation by application focuses on adult dogs and puppies, acknowledging the varying health needs at different life stages. With over 45% of pet owners seeking specific supplement formats for easier administration, the type-based segmentation is crucial. Similarly, around 40% of consumers are now tailoring supplement usage based on age, ensuring precise joint support and better long-term mobility outcomes.

By Type

• Biscuits: Biscuits remain a favored choice for 31% of dog owners due to their palatability and ease of administration. Among senior dogs, 27% of owners prefer biscuits enriched with glucosamine. These crunchy formats are also increasingly available with added omega-3 and MSM, contributing to a 22% rise in multi-benefit product preference.
• Soft Treats: Soft treats account for 36% of the total demand, especially among small-breed and aging dogs. Over 34% of consumers opt for soft chews for better digestibility and ease of chewing. Their appealing taste profiles drive a 29% higher repeat purchase rate compared to other forms.
• Chewable Tablets: Chewable tablets are used by 19% of dog owners, particularly those focused on precise dosing and higher ingredient concentration. These formats are preferred by 21% of vet clinics for prescription use. Formulas with time-release technology have seen a 16% boost in demand.
• Others: Other formats, including liquid drops and powders, are gaining traction, representing 14% of product consumption. Around 11% of owners with picky eaters use mix-in powders, while liquid versions see 9% more use in multi-pet households due to versatility.

By Application

• Adult Dog: Supplements for adult dogs dominate the segment, with 68% of users purchasing hip and joint products for pets aged 2 years and older. Within this segment, 42% of adult dogs on supplements show improved joint flexibility. Preventive usage is growing, with 37% of adult dog owners using supplements proactively.
• Puppy: Puppy-targeted supplements account for 32% of the market. Among large breed puppies, 28% are given joint health products to support proper skeletal development. With early intervention, 26% of owners have reported better posture and reduced risks of hip dysplasia during growth phases.

Regional Outlook

The global hip and joint supplement for dog market displays varied growth trends across different regions. North America leads in product consumption due to rising awareness among pet parents, accounting for over 38% of total market share. Europe follows with a robust adoption rate, especially in Western countries where 31% of pet owners opt for supplements as a preventive measure. Asia-Pacific is witnessing rapid growth, driven by urbanization and increasing pet humanization, contributing to nearly 24% of global demand. Meanwhile, the Middle East & Africa region is gradually emerging, supported by rising disposable income and a 19% uptick in premium pet product sales. The regional outlook shows that tailored formulations and pet health education campaigns are shaping market penetration and adoption dynamics across these geographies.

North America

North America remains the largest consumer of hip and joint supplements for dogs, accounting for over 38% of global market consumption. In the U.S., more than 45% of dog owners use daily supplements for mobility support. Canada has seen a 26% increase in premium soft chew purchases over the past two years. Retail stores in the region report that 33% of their pet health product shelf space is now dedicated to joint and mobility supplements. The presence of leading pet care brands and frequent veterinarian recommendations contribute to higher penetration.

Europe

Europe holds approximately 31% of the market share, led by countries like Germany, the U.K., and France. In Germany, 28% of pet owners regularly give supplements to dogs over five years old. The U.K. has seen a 21% rise in demand for plant-based and organic joint supplements. France recorded a 19% increase in joint health-related veterinary prescriptions. Online retail in Europe for dog supplements has expanded by 34% in the past year, enabling easier access and education about joint health support for dogs.

Asia-Pacific

Asia-Pacific commands around 24% of the global demand, fueled by urban pet adoption and rising income levels. China has witnessed a 42% surge in hip and joint supplement usage in the past three years. In India, demand for chewable and palatable formats grew by 36% as pet owners increasingly focus on preventive care. Japan’s aging dog population has led to a 31% increase in joint-related supplement sales. E-commerce plays a major role in this region, with 29% of pet supplement purchases occurring online due to accessibility and product variety.

Middle East & Africa

The Middle East & Africa region accounts for a growing 7% share of the global market. The United Arab Emirates and South Africa lead this growth, with a 22% year-over-year increase in pet wellness product consumption. In the Gulf countries, 18% of households now regularly include mobility supplements in their dog’s diets. South Africa saw a 15% increase in demand for vet-approved joint supplements in the past two years. Increasing awareness about pet wellness and the availability of imported supplement brands contribute to this emerging market's expansion.

LIST OF KEY Hip and Joint Supplement For Dog Market COMPANIES PROFILED

Technological Advancements

Innovations in the hip and joint supplement for dog market are reshaping pet healthcare with targeted, science-backed formulations. About 47% of manufacturers have adopted microencapsulation technology to preserve the bioavailability of active ingredients like glucosamine and chondroitin. Another 38% of brands are integrating omega-3 fatty acid delivery systems to enhance anti-inflammatory effects. The use of cold-extrusion methods has increased by 32%, preserving nutrient integrity in soft chews and biscuits. AI-based analytics are used by 29% of veterinary supplement companies to personalize dosage recommendations based on breed, weight, and health history. Probiotic-infused joint supplements have seen a 27% market rise due to digestive synergy. Additionally, 22% of new formulations use turmeric and Boswellia extracts backed by recent clinical trials. Technology is also improving packaging; 34% of brands now offer resealable, moisture-resistant packs to enhance product longevity. These advancements are contributing significantly to consumer trust and improved pet mobility outcomes globally.

NEW PRODUCTS Development

The hip and joint supplement market for dogs has seen a surge in new product development focused on natural and breed-specific formulations. About 41% of new products in 2023 and 2024 are organic, free from artificial preservatives. Soft chews remain the most innovated segment, with 36% of launches offering new flavors like peanut butter, chicken, and salmon. Companies like Blue Buffalo and VetIQ introduced multivitamin-joint combo supplements, accounting for a 33% increase in multifunctional pet supplement sales. Moreover, 29% of new launches cater specifically to senior dogs with age-adjusted dosages. Puppy-focused products increased by 24%, targeting early-stage joint health support. About 18% of companies have begun using human-grade ingredients to improve quality assurance. Gluten-free and allergen-friendly variants account for 22% of new market entries. With pet owners becoming more ingredient-conscious, these developments are setting the tone for the market’s next innovation cycle.

Recent Developments

• Mars Petcare: In 2023, Mars launched a glucosamine-rich chew tailored for large breed dogs, leading to a 21% rise in monthly subscription purchases across U.S. markets.
• Nestle Purina: In early 2024, Purina rolled out breed-specific joint care soft chews, increasing their direct-to-consumer sales by 18% within three months.
• VetIQ: Introduced a new turmeric-based hip and joint supplement in Q2 2023, resulting in a 25% rise in sales in natural pet product segments.
• EverRoot: Collaborated with veterinary nutritionists in late 2023 to launch a dual-action anti-inflammatory chew, which captured 16% of online sales in its category.
• Unicharm: Expanded into the Southeast Asian market in 2024 with a new collagen-boosting chew, reporting 23% growth in their pet health division.

REPORT COVERAGE

The Hip and Joint Supplement For Dog Market report covers an extensive analysis of type, application, regional demand, technological innovation, and competitive landscape. Over 61% of the market is driven by chewable formats like soft treats and tablets. Functional ingredients such as glucosamine, chondroitin, MSM, and omega-3s appear in 74% of the product formulations. In terms of application, adult dogs constitute about 68% of supplement consumption, followed by puppies at 32%. Regionally, North America leads with a 38% share, followed by Europe at 31%, Asia-Pacific at 24%, and the Middle East & Africa at 7%. Veterinary clinics remain the primary distribution channel, influencing 53% of purchase decisions, while e-commerce accounts for 29% of all transactions. Key manufacturers focus on clean-label ingredients, flavor innovation, and research-backed efficacy to maintain competitive advantage. The report also highlights the impact of consumer awareness, especially among millennial pet parents who account for nearly 49% of all supplement purchases.